Rivka Gluck News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rivka Gluck. Real-time updates on events, politics, business and more.

Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

May 3, 2022

/PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today announced...

Evan Thompson Simrat Randhawa Rivka Gluck Marino Garcia Tellus Bioventures Tomas Kiselak

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Rivka Gluck News Today

Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

Explore More Categories